PM 10-K Annual Reports

Philip Morris International Inc. (PMI) reported strong financial performance for the fiscal year ended December 31, 2025. Net revenues increased by 7.3% to $40.6 billion, driven by a favorable pricing variance in combustible tobacco and significant growth in smoke-free product (SFP) volumes, which more than offset a decline in cigarette volumes. Diluted Earnings Per Share (EPS) saw a substantial increase of 60.6% to $7.26, benefiting from higher operating income, favorable currency movements, and improved income from equity investments. The company's strategic focus on its smoke-free portfolio continues to yield positive results, with SFPs driving overall volume growth. PMI also demonstrated a commitment to shareholder returns through significant dividend payments and share repurchases. The company provided guidance for 2026, expecting broadly stable total cigarette and SFP shipment volume, with high-single digit SFP shipment volume growth and a cigarette shipment volume decline of around 3%. PMI's ongoing transformation towards a smoke-free future remains a key strategic priority, supported by continued investment in R&D and commercialization of its innovative products.

Philip Morris International Inc. (PM) reported robust growth in its smoke-free product portfolio, driven by the strong performance of IQOS and ZYN brands, which continues to be a key driver of the company's transformation. Net revenues increased by 7.7% to $37.9 billion, with smoke-free products contributing significantly to this growth. Despite a notable impairment charge of $2.3 billion related to its investment in Rothmans, Benson & Hedges Inc. (RBH), the company demonstrated resilience, with operating income increasing by 16.0% year-over-year. PMI's strategic focus on a smoke-free future is evident in its continued investment in R&D and commercialization of these products. The company is navigating a complex regulatory and economic landscape, including inflationary pressures and geopolitical events, but maintains a strong financial position with significant cash flows from operations and ample liquidity.

Philip Morris International Inc. (PMI) has filed its 2023 10-K, highlighting a transformative year marked by the integration of Swedish Match and strategic investments in a smoke-free future. The company reported a net revenue increase of 10.7% to $35.2 billion, driven by strong pricing and growth in heated tobacco unit (HTU) volume, despite a slight decline in cigarette volume. Diluted EPS saw a decrease of 13.6% to $5.02, impacted by significant acquisition-related costs, impairment charges, and war-related expenses. PMI's strategic pivot towards smoke-free products (SFPs) continues, with SFPs contributing substantially to net revenues. The acquisition of Swedish Match has significantly expanded PMI's oral nicotine portfolio, notably with the ZYN brand in the U.S. Looking ahead, PMI is focused on accelerating its smoke-free transformation, which includes continued investment in product development, scientific substantiation, and market expansion. Key risks remain related to regulatory environments, particularly concerning RRPs, and the ongoing geopolitical instability in Eastern Europe. The company also announced a global patent settlement with British American Tobacco (BAT), resolving all ongoing patent infringement litigation related to heated tobacco and vapor products, which is expected to allow for continued product innovation.

Philip Morris International Inc. (PM) reported its 2022 fiscal year results, marked by significant strategic shifts and a notable acquisition. The company's transformation towards a smoke-free future remains a core focus, evidenced by continued investment in reduced-risk products (RRPs). A pivotal event was the acquisition of Swedish Match AB in November 2022, bolstering PMI's position in the oral nicotine market with the ZYN brand and complementing its IQOS heat-not-burn offering. This move is expected to accelerate the company's smoke-free ambitions. Financially, PMI reported net revenues of $31.8 billion, a slight increase from the previous year, driven by growth in smoke-free products and favorable pricing, although impacted by currency headwinds and charges related to the war in Ukraine. Diluted EPS saw a minor decrease. The company also reached an agreement with Altria Group, Inc. to reacquire U.S. commercialization rights for IQOS, effective May 2024, signaling a strategic move to directly control its key smoke-free product in a major market. Despite geopolitical challenges and ongoing regulatory scrutiny, PMI is actively managing its portfolio and investing in future growth drivers.

Philip Morris International Inc. (PM) reported strong financial performance in 2021, with net revenues increasing by 9.4% to $31.4 billion. This growth was primarily driven by a significant increase in reduced-risk product (RRP) net revenues, up 33.5% to $9.1 billion, led by the continued strength of the IQOS brand. Despite a decline in cigarette shipment volumes globally, the company's strategic focus on transitioning to a smoke-free future is evident in the robust performance of its RRP portfolio. The company also announced its ambition to expand into wellness and healthcare, highlighted by strategic acquisitions of Vectura Group PLC and Fertin Pharma A/S. While facing ongoing regulatory challenges and the persistent decline in cigarette consumption, PM's ability to drive RRP adoption and its diversified product strategy position it for continued growth in the evolving tobacco and nicotine market. The company remains committed to returning capital to shareholders, evidenced by significant dividend payments and ongoing share repurchases.

Philip Morris International Inc. (PM) reported net revenues of $28.7 billion for the year ended December 31, 2020, a decrease of 3.7% from 2019, primarily impacted by the COVID-19 pandemic. Despite the revenue dip, diluted earnings per share (EPS) saw a significant increase of 11.9% to $5.16, driven by strong operational performance and a lower effective tax rate. The company continues its strategic pivot towards a "smoke-free future," with its Reduced-Risk Products (RRPs) segment showing robust growth, with net revenues increasing by 21.9% to $6.8 billion. The company's strategy to transition smokers to RRPs, exemplified by its IQOS product line, is a key focus. While combustible product revenues declined, the substantial growth in RRPs highlights the company's successful product innovation and market penetration in this category. Management remains confident in its ability to navigate challenges such as increasing regulation and evolving consumer preferences by focusing on its transformation agenda and driving the adoption of its smoke-free alternatives.

Philip Morris International Inc. (PM) reported total net revenues of $29.8 billion for the year ended December 31, 2019, a slight increase of 0.6% from 2018. This growth was primarily driven by favorable pricing and increased volume/mix from its Reduced-Risk Products (RRPs), particularly heated tobacco units (HTUs) and IQOS devices in the EU and Russia. Despite a decline in cigarette shipment volume, the company saw a significant 44.2% increase in HTU shipment volume, reaching 59.7 billion units, underscoring the growing importance of its smoke-free portfolio. However, diluted earnings per share (EPS) decreased by 9.3% to $4.61, impacted by substantial one-time charges including asset impairment and exit costs, a Canadian tobacco litigation-related expense, a loss on the deconsolidation of its Canadian subsidiary (RBH), and a Russia excise and VAT audit charge. The company continues to navigate a challenging operating environment characterized by declining cigarette consumption in many markets, increased taxes, and evolving regulations. PMI's strategic focus remains on transforming the tobacco industry towards a smoke-free future by developing and commercializing RRPs. The strong growth in HTU sales, coupled with the FDA's authorization of its Platform 1 product for sale in the U.S. (licensed to Altria), signals progress in this strategic shift, although significant investments in RRP development and commercialization are expected to continue impacting near-term profitability.

Philip Morris International (PM) reported a net revenue increase of 3.1% to $29.6 billion for the fiscal year ended December 31, 2018. This growth was primarily driven by favorable pricing across key markets and a significant increase in heated tobacco unit (HTU) volume, particularly in the European Union. Diluted Earnings Per Share (EPS) saw a substantial increase of 30.9% to $5.08, largely attributed to the positive impact of the U.S. Tax Cuts and Jobs Act of 2017, which reduced the company's effective tax rate, and lower interest expenses due to debt optimization. The company continues its strategic transformation towards a smoke-free future with its Reduced-Risk Products (RRPs), notably IQOS, which saw a 14.2% increase in shipment volume. Despite the overall positive financial performance, the company faces ongoing challenges related to declining cigarette consumption in many markets and increasing regulatory scrutiny across the industry.

Philip Morris International (PM) reported its 2017 annual results, showcasing solid revenue growth and operational performance. Net revenues increased by 4.2% to $78.1 billion, driven by price increases and favorable volume/mix, partially offset by currency headwinds. The company's strategic focus on smoke-free products is evident, with significant growth in Reduced-Risk Products (RRPs), particularly IQOS, which generated $3.8 billion in net revenue in 2017, a substantial increase from the prior year. Despite a challenging regulatory environment and ongoing shifts in consumer preferences, PM demonstrated resilience, with operating income rising 6.4% to $11.5 billion. A significant event impacting the year was the U.S. Tax Cuts and Jobs Act, which led to a one-time provisional tax charge of $1.6 billion, negatively affecting diluted EPS. However, excluding this tax impact and currency fluctuations, adjusted diluted EPS showed a healthy increase, indicating strong underlying operational performance. Looking ahead, PM projected continued growth for 2018, signaling confidence in its business strategy. The company's ongoing investment in RRPs underscores its commitment to transforming its product portfolio and long-term growth trajectory. Investors should note the increasing contribution of RRPs to overall revenue and the company's proactive management of currency risks and regulatory landscapes. The company's financial health remains robust, supported by strong operating cash flow and a well-managed debt structure, positioning it for continued shareholder returns.

Philip Morris International Inc. (PM) reported solid results for the fiscal year ended December 31, 2016. The company demonstrated resilience by increasing diluted earnings per share (EPS) by 1.4% to $4.48, despite a 4.1% decrease in total cigarette shipment volume. This growth was driven by strategic price increases across its portfolio and a reduction in marketing, administration, and research costs, which more than offset unfavorable currency movements and a slight decline in volume/mix. The company's diversified geographic segments contributed to this performance, with the EU, EEMA, Asia, and Latin America & Canada regions all showing contributions to operating income growth, primarily through pricing actions. A significant strategic focus for PMI is the development and commercialization of Reduced-Risk Products (RRPs). The company reported substantial growth in IQOS Consumables shipment volume, reaching 7.4 billion units, up from 396 million in the prior year, indicating growing adoption of its innovative products. This strategic shift towards RRPs is a key long-term growth driver, aiming to transition adult smokers to potentially less harmful alternatives. Despite the ongoing challenges in the tobacco industry, including declining cigarette volumes and increasing regulatory pressures, PMI's financial performance in 2016 highlights its ability to manage costs, execute pricing strategies, and invest in future growth areas like RRPs.

Philip Morris International (PM) reported its 2015 annual results, highlighting a slight decrease in overall cigarette shipment volume, down 1.0% year-over-year to 847.3 billion units, aligning with an estimated 2.6% decline in the broader international market. Despite this volume pressure, the company saw growth in key brands like Marlboro and Philip Morris, driven by pricing strategies and market share gains in several important regions. The company's financial performance was significantly impacted by unfavorable currency movements, particularly against the U.S. dollar, which reduced net revenues and operating income. PM is actively investing in the development and commercialization of Reduced-Risk Products (RRPs), with iQOS showing promising initial launches in select markets. The company faced increased operational costs and a challenging regulatory environment globally, as detailed in its risk factors, including potential impacts from excise tax increases and stricter marketing regulations. The company's financial position remained solid, supported by strong operating cash flow, though it continued to manage significant long-term debt.

Philip Morris International Inc. (PMI) for the year ending December 31, 2014, demonstrated resilience despite facing significant currency headwinds and restructuring charges. While net revenues remained relatively flat year-over-year, a substantial decline in diluted EPS was primarily driven by unfavorable currency movements, particularly impacting the Argentine peso, Australian dollar, Canadian dollar, Euro, Indonesian rupiah, Japanese yen, Kazakhstan tenge, Russian ruble, Turkish lira, and the Ukraine hryvnia. The company also incurred significant asset impairment and exit costs related to factory closures and restructuring initiatives. Despite these challenges, PMI continued to execute its pricing strategies, which helped offset some of the negative impacts on operating income. The company also made strategic acquisitions, including Nicocigs Limited, to expand its presence in the e-vapor market. Looking ahead, PMI provided guidance for 2015, forecasting a decline in reported diluted EPS, largely due to continued currency pressures. However, the company emphasized its focus on innovation, particularly with its reduced-risk product (RRP) portfolio, including iQOS, signaling a strategic shift towards developing and commercializing products with the potential to reduce individual risk and population harm.

Philip Morris International Inc. (PM) presents its 2013 annual report, detailing a global business focused on manufacturing and selling cigarettes and other tobacco products in markets outside the United States. The company boasts a strong portfolio of international and local brands, led by Marlboro, which accounts for a significant portion of its shipment volume. PM operates across four key geographic segments: the European Union, Eastern Europe, Middle East & Africa, Asia, and Latin America & Canada, with Asia and the EU being the largest contributors to operating companies income. Strategic initiatives during 2013 included restructuring its Egyptian business for enhanced profitability, entering into a strategic framework with Altria for the commercialization of e-cigarettes and reduced-risk tobacco products, and acquiring significant stakes in distributors and joint ventures in Russia and Algeria to strengthen market presence. The company also achieved full ownership of its Mexican tobacco business. A key strategic priority highlighted is the development of Reduced-Risk Products (RRPs), with a significant investment in a new manufacturing facility in Italy to produce these next-generation products. Despite a slight decrease in total cigarette shipments, PM maintains a substantial share of the international market, underscoring its established global footprint.

Philip Morris International (PM) in its 2013 10-K filing for the fiscal year ended December 30, 2012, outlines its global operations as a leading manufacturer and seller of cigarettes and other tobacco products outside the United States. The company highlights its strong market positions in over 180 markets, driven by its flagship brand, Marlboro, which accounted for approximately 33% of its 2012 shipment volume. PM operates across four key geographic segments: European Union (EU), Eastern Europe, Middle East & Africa (EEMA), Asia, and Latin America & Canada. The company is actively managing a portfolio of international and local brands, aiming to benefit from the trend of international brands expanding their share in numerous markets. Significant attention is given to the evolving business environment, including increasing governmental regulations, substantial tax increases on tobacco products, and ongoing litigation. PM is proactively addressing these challenges through strategic marketing, diversified distribution channels, and a focus on innovation, particularly in developing 'next generation products' (NGPs) aimed at reducing the risks associated with smoking. The company's financial health is supported by strong brand equity and a global operational footprint, though it remains susceptible to currency fluctuations and the inherent risks of the tobacco industry.

Philip Morris International Inc. (PM) reported its 2011 fiscal year results, highlighting continued global market presence and strategic growth initiatives. The company operates in approximately 180 countries, with its premium brand, Marlboro, accounting for a significant portion of its total shipment volume. PM emphasized its market leadership and its efforts to adapt to evolving regulatory landscapes and consumer preferences. The company's diversified geographic segments, including the EU, EEMA, Asia, and Latin America & Canada, contribute to its global revenue streams, with the Asia segment showing notable growth in its contribution to operating income. PM also detailed its ongoing efforts in research and development, particularly in exploring innovative Next Generation Products (NGPs) with the potential for reduced risk, alongside continued investment in conventional product enhancements. The company remains focused on its distribution and sales strategies, tailored to each market's characteristics, and emphasizes strong relationships with trade partners. Key financial highlights and operational strategies are further detailed in the accompanying Management's Discussion and Analysis. The report also outlines various risk factors, including regulatory changes, litigation, currency fluctuations, and competition, which are critical considerations for investors.

Philip Morris International Inc. (PM) reported its annual results for the fiscal year ended December 31, 2010, in its Form 10-K filed on February 25, 2011. The company, a leading global tobacco products manufacturer operating outside the United States, highlighted a 4.1% increase in total cigarette shipments to 899.9 billion units, reaching a market share of approximately 16.0% internationally (excluding China). This growth was driven by strong performance in key markets and strategic acquisitions, including the combination of its Philippine operations with Fortune Tobacco Corporation and the acquisition of Swedish Match South Africa. The company also emphasized its extensive brand portfolio, led by Marlboro, and its diversified geographic presence across four reporting segments: European Union, Eastern Europe, Middle East & Africa (EEMA), Asia, and Latin America & Canada. Despite a generally challenging regulatory environment and ongoing litigation, PM demonstrated resilience in its market position and continued to invest in brand building and operational efficiencies. The report indicates a focus on developing potentially reduced-risk tobacco products and managing significant risks associated with tax increases, evolving regulations, currency fluctuations, and competitive pressures. The company maintained a strong liquidity position, supported by its financial performance and share repurchase programs, underscoring its commitment to shareholder value while navigating the complexities of the global tobacco industry.

Philip Morris International Inc. (PM) for the fiscal year ended December 31, 2009, reported strong performance in markets outside the United States, driven by its premium brand portfolio led by Marlboro. The company's strategy focused on selective acquisitions to strengthen its brand portfolio and geographic reach. Significant acquisitions in 2009 included Swedish Match South Africa and the agreement to purchase Protabaco Ltda. in Colombia. Despite facing increasing regulatory scrutiny and excise taxes globally, PM maintained a dominant market share in many regions, demonstrating resilience in its core business. Financially, PM continued to emphasize shareholder returns through its share repurchase program, authorizing a new $12 billion program to follow its existing $13 billion program. The company operates across four key geographic segments: European Union, Eastern Europe, Middle East and Africa (EEMA), Asia, and Latin America & Canada, with the EU and EEMA regions contributing the largest portions of operating companies income. The report also details ongoing litigation, primarily related to tobacco products, though the company notes historical success in defending against such claims.

Philip Morris International Inc. (PM) has filed its 2008 Form 10-K, reflecting its first full year as an independent, publicly traded company following its spin-off from Altria Group, Inc. on March 28, 2008. The company's business operates exclusively outside the United States, selling cigarettes and other tobacco products in approximately 160 countries. PM International holds leading market share positions in many of these regions, with its flagship brand, Marlboro, accounting for a significant portion of its sales volume. For the fiscal year ended December 31, 2008, PM International reported increased shipment volumes, driven by its strong brand portfolio and strategic market presence. The company also engaged in significant corporate activities, including the acquisition of Rothmans Inc. in Canada and increased ownership in its Mexican operations. The report details the company's operational structure across four geographic segments: European Union, Eastern Europe, Middle East & Africa, Asia, and Latin America & Canada. Investors should note the ongoing risks associated with the tobacco industry, including increased taxation, stringent regulatory environments, litigation, and currency fluctuations, all of which are discussed extensively.